University Hospital Ostrava

At University Hospital Ostrava, clinical research in Nervous System Diseases focuses on conditions such as acute ischemic stroke, epilepsy, and mild cognitive impairment due to Alzheimer’s disease. These studies are designed to evaluate new treatment options, improve symptom control, and better understand how neurological disorders progress.

• Testing a potential therapy for acute ischemic stroke
• Evaluating add-on treatment for focal seizures in epilepsy
• Assessing a new approach for Alzheimer’s disease-related cognitive decline
• Exploring genetic factors that may influence treatment response in psychoses

The department’s work in Neurologická klinika FNO a LF OU reflects a strong interest in both brain health and psychiatric research, with a focus on helping improve outcomes for patients with complex neurological and mental health conditions.

Research in Neoplasms includes studies in melanoma, breast cancer, and renal cell carcinoma, with additional attention to myelodysplastic syndromes. The main goals are to test new cancer therapies, reduce the risk of recurrence, and improve long-term disease control after standard treatment.

• Evaluating immunotherapy combinations for melanoma
• Preventing recurrence after surgery for stage IIb/c melanoma
• Studying endocrine treatment strategies in early breast cancer
• Assessing adjuvant therapy for renal cell carcinoma

This cancer-focused portfolio also includes studies aimed at improving treatment response in myelodysplastic syndrome and related blood disorders, showing a broad commitment to oncology research at University Hospital Ostrava.

Within Hemic and Lymphatic Diseases, the site is studying myelodysplastic syndrome and anemia due to lower-risk myelodysplastic syndromes. These trials are focused on improving blood counts, reducing transfusion needs, and finding better ways to support patients living with chronic marrow disorders.

• Investigating a new treatment for lower-risk myelodysplastic syndromes
• Comparing approaches for transfusion independence
• Evaluating options for anemia management in MDS

Research in this area aims to make everyday care more effective for people with persistent blood-related disease, while also helping clinicians identify treatments that may offer better durability and safety.

Clinical trials in Cardiovascular Diseases are addressing atherosclerotic cardiovascular disease and elevated lipoprotein(a). The purpose of this research is to lower major heart-related risks and evaluate whether newer therapies can improve prevention in people with established cardiovascular disease.

• Testing a treatment to reduce the risk of heart attack and related events
• Studying therapies for patients with elevated lipoprotein(a)
• Evaluating cardiovascular risk reduction in ASCVD

These studies reflect growing interest in personalized prevention strategies for patients who remain at high risk despite standard care.

Work in Eye Diseases centers on macular edema secondary to retinal vein occlusion. The trials are designed to assess how well new eye treatments improve vision and control retinal swelling, with the goal of preserving sight and enhancing daily functioning.

• Evaluating vision improvement in retinal vein occlusion
• Assessing treatment effectiveness for macular edema
• Studying safety and benefit of a new ophthalmic therapy

This area highlights the site’s involvement in practical, patient-centered research aimed at protecting visual health.

Research in Skin and Connective Tissue Diseases focuses on hidradenitis suppurativa, a painful inflammatory skin condition that can significantly affect quality of life. The trials are examining new therapies to reduce symptoms, inflammation, and disease burden.

• Testing a treatment for moderate to severe hidradenitis suppurativa
• Evaluating symptom control and safety in hidradenitis suppurativa
• Supporting development of improved options for chronic skin inflammation

These studies show an effort to improve care for a difficult-to-manage dermatologic disease that often requires long-term treatment.

Trials in Immune System Diseases at University Hospital Ostrava are exploring therapies that target inflammatory and immune-driven conditions. The main emphasis is on finding better ways to control disease activity and improve patient outcomes through more precise treatment approaches.

• Investigating immune-targeted treatment for chronic inflammatory disease
• Assessing the effectiveness of newer immunotherapy strategies
• Studying treatment response in immune-mediated conditions

This area overlaps with oncology and skin disease research, reflecting the broad role of immune mechanisms across several clinical specialties.

The site also includes research in Bacterial Infections and Mycoses, where clinical studies are aimed at improving treatment options for infection-related conditions and supporting better disease control in patients with complex medical needs.

• Exploring new approaches for infection-related disease management
• Assessing treatment effectiveness in infectious disease settings
• Supporting research on therapies for bacterial and fungal conditions

Although smaller in scope than the neurological and oncology portfolios, this area adds to the site’s broad clinical research profile.

Research in Behavioral Disciplines and Activities is represented by studies related to psychoses and treatment response. The aim is to improve understanding of how behavioral and biological factors interact in mental health care, while supporting more effective use of therapies.

• Studying genetic influences on response in psychosis
• Improving knowledge of treatment variability in mental health
• Supporting more individualized psychiatric care

This work complements the broader neurological research program and adds an important behavioral health dimension to the site’s clinical trial activity.